Welcome to the Brain & Behavior Lab Monthly Newsletter Vol. 1, Issue 5, September 2024

Dr. Modestino's Director's Blog

 

September 2024: A Month in Review of Neuroscience News Articles Referring to Original Research

 
September 2024 Neuroscience

Breaking news!

Check out our latest research endeavors to examine the underlying genetic relationship between ADHD and narcolepsy

 
Upcoming Research
 

This blog describes how the concept emerged within Dr. Modestino's research interests.

 
Blog about this concept

Breaking news!

A Geneticist has joined our lab!

 

Alireza (Ali) Sharafshah, Ph.D.

 
Please welcome Ali to our lab!

Jakai Kelly and Rachael Sanford

 

Two students have joined the lab as research interns for the fall 2024 semester!

 

 
Please welcome them to our lab!

Our Current Research:

We have two survey studies: one about Rejection Sensitivity Dysphoria (RSD) in ADHD and another about the triggers of attacks in those with migraines and narcolepsy. We are looking for volunteers for our research! Click the link below!

 
Current Research

Rejection Sensitivity Dysphoria (RSD) in ADHD: Survey Study

Triggers of hemiplegic attacks in those with hemiplegic migraines as well as catapletic attacks in those with narcolepsy: Survey Study

 

 
Publications

Here is a list of our recent publications:

 

  • Dodson, W.W., Modestino, E.J., Titiz-Ceritoğlu, H., & Zayed, B. (2024) Rejection Sensitivity Dysphoria in Attention-Deficit/Hyperactivity Disorder: A Case Series.  Acta Scientific Neurology, 7(8): 23-30. DOI: 10.31080/ASNE.2024.07.0762

     

  • Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, et al. (2024). Solving the Global

    Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration. Therapy J Addict Psychiatry 8(1): 50-96. (Drs. Blum, Modestino, and Thanos are co-authors)

​

  • Modestino, E.J., Bowirrat A, Baron, D., Thanos, P.K., Hanna, C., Bagchi, D., Braverman, E.R., Dennen, C.A., Badgaiyan, R.D., Pollack, A.R., Lewandrowski, K.-U., Sharafshah, A., Gold, M.S., & Blum, K. (2024) Is there a natural, non-addictive, and non-anti-reward, safe, gene-based solution to treat Reward Deficiency Syndrome (RDS)? KB220 variants vs. GLP-1 analogs. J Addict Psychiatry, 8(1): 34-49

​

  • Modestino, E.J., Bowirrat, A., Lewandowski, K.-U., Sharafshah,  A., Badgaiyan, R.D., Thanos, P.K., Baron, D., Dennen, C.A., Elman, I., Sunder, K., Murphy, K.T., & Blum, K. (2024). Hemiplegic migraines exacerbated using an injectable GLP-1 agonist for weight loss.  Acta Scientific Neurology, 7(5): 12-18.  DOI: 10.31080/ASNE.2024.07.0731

​

  • Dodson, W.W., & Modestino, E.J. (2024). Have we placed the cart before the horse by using alpha-2A agonists to treat rejection sensitivity dysphoria in ADHD? Current Psychopharmacology, e050424228696.  DOI: 10.2174/0122115560297397240404071044

     

  • Blum, K., Bowirrat, A., Baron, D., Elman, I., Makale, M. T., Cadet, J. L., Thanos, P. K., Hanna, C., Ahmed, R., Gondre-Lewis, M. C., Dennen, C. A., Braverman, E. R., Soni, D., Carney, P., Khalsa, J., Modestino, E. J., Barh, D., Bagchi, D., Badgaiyan, R. D., … Gold, M. S. (2024). Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences. Gene & Protein in Disease, 3(1), 1966. https://doi.org/10.36922/gpd.1966

We have added a new section to our website to provide informational brochures. We will be adding to this over the fall semester with the help of our interns!

 
Brochures

Visit our lab shop for lab merch!

 
Lab Shop
Subscribe to our monthly newsletter
Subscribe

Visit our social media accounts

Check out our site  
This email was created with Wix.‌ Discover More